Epidemiology of multiple herpes viremia in previously immunocompetent patients with septic shock

Clinical Infectious Diseases

Volumn 64, Issue 9, 2017, Pages 1204-1210

  Ong, David S Y ^a   Bonten, Marc J M ^a,b   Spitoni, Cristian ^b,c   Lunel, Frans M Verduyn ^a   Frencken, Jos F ^a,b   Horn, Janneke ^a   Schultz, Marcus J ^a   Der Poll, Tom Van ^d,e   Klouwenberg, Peter M C Klein ^a   Cremer, Olaf L ^a  

^a Department of Medical Microbiology ^*  (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

^d Center of Experimental and Molecular Medicine and Division of Infectious Diseases   (Netherlands)

^e UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Cmegalovirus; Epstein Barr virus; Human herpesvirus 6; Mortality; Reactivation

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL OUTCOME; COHORT ANALYSIS; CYTOMEGALOVIRUS; EPIDEMIOLOGICAL DATA; EPSTEIN BARR VIRUS; FEMALE; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 6; IMMUNOCOMPETENCE; INCIDENCE; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SEPTIC SHOCK; VARICELLA ZOSTER VIRUS; VIREMIA; VIRUS DETECTION; VIRUS REACTIVATION; CLASSIFICATION; COMPLICATION; HERPESVIRIDAE; ISOLATION AND PURIFICATION; MIDDLE AGED; NETHERLANDS; PROSPECTIVE STUDY; TERTIARY CARE CENTER; VIROLOGY;

AGED; FEMALE; HERPESVIRIDAE; HERPESVIRIDAE INFECTIONS; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; NETHERLANDS; PROSPECTIVE STUDIES; SHOCK, SEPTIC; TERTIARY CARE CENTERS; VIREMIA;

EID: 85020034178     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cix120     Document Type: Article

References (34)

1. Limaye AP, Boeckh M. CMV in critically ill patients: pathogen or bystander? Rev Med Virol 2010; 20:372-9.
2. Osawa R, Singh N. Cytomegalovirus infection in critically ill patients: a systematic review. Crit Care 2009; 13:R68.
3. Walton AH, Muenzer JT, Rasche D, et al. Reactivation of multiple viruses in patients with sepsis. PLoS One 2014; 9:e98819.
4. Ong DS, Spitoni C, Klein Klouwenberg PM, et al. Cytomegalovirus reactivation and mortality in patients with acute respiratory distress syndrome. Intensive Care Med 2016; 42:333-41.
5. Chiche L, Forel JM, Roch A, et al. Active cytomegalovirus infection is common in mechanically ventilated medical intensive care unit patients. Crit Care Med 2009; 37:1850-7.
6. Coisel Y, Bousbia S, Forel JM, et al. Cytomegalovirus and herpes simplex virus effect on the prognosis of mechanically ventilated patients suspected to have ventilator- associated pneumonia. PLoS One 2012; 7:e51340.
7. Limaye AP, Kirby KA, Rubenfeld GD, et al. Cytomegalovirus reactivation in critically ill immunocompetent patients. JAMA 2008; 300:413-22.
8. Ziemann M, Sedemund-Adib B, Reiland P, Schmucker P, Hennig H. Increased mortality in long-term intensive care patients with active cytomegalovirus infection. Crit Care Med 2008; 36:3145-50.
9. Ong DSY, Klein Klouwenberg PMC, Verduyn Lunel FM, et al. Cytomegalovirus seroprevalence as a risk factor for poor outcome in acute respiratory distress syndrome∗. Crit Care Med 2015; 43:394-400.
10. Libert N, Bigaillon C, Chargari C, et al. Epstein-Barr virus reactivation in critically ill immunocompetent patients. Biomed J 2015; 38:70-6.
11. Razonable RR, Fanning C, Brown RA, et al. Selective reactivation of human herpesvirus 6 variant a occurs in critically ill immunocompetent hosts. J Infect Dis 2002; 185:110-3.
12. Lepiller Q, Sueur C, Solis M, et al. Clinical relevance of herpes simplex virus viremia in intensive care unit patients. J Infect 2015; 71:93-100.
13. Klein Klouwenberg PMC, Ong DSY, Bos LDJ, et al. Interobserver agreement of Centers for Disease Control and Prevention criteria for classifying infections in critically ill patients. Crit Care Med 2013; 41:2373-8.
14. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Springer-Verlag: 2003:530-8.
15. Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 2016; 315:801-10.
16. De Paschale M, Clerici P. Serological diagnosis of Epstein-Barr virus infection: problems and solutions. World J Virol 2012; 1:31-43.
17. Zerr DM, Meier AS, Selke SS, et al. A population-based study of primary human herpesvirus 6 infection. N Engl J Med 2005; 352:768-76.
18. Nardone A, de Ory F, Carton M, et al. The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region. Vaccine 2007; 25:7866-72.
19. van Doornum GJ, Guldemeester J, Osterhaus AD, Niesters HG. Diagnosing herpesvirus infections by real-time amplification and rapid culture. J Clin Microbiol 2003; 41:576-80.
20. Niesters HG, van Esser J, Fries E, Wolthers KC, Cornelissen J, Osterhaus AD. Development of a real-time quantitative assay for detection of Epstein-Barr virus. J Clin Microbiol 2000; 38:712-5.
21. de Pagter PJ, Schuurman R, Visscher H, et al. Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome. Biol Blood Marrow Transplant 2008; 14:831-9.
22. Wolkewitz M, Cooper BS, Bonten MJ, Barnett AG, Schumacher M. Interpreting and comparing risks in the presence of competing events. BMJ 2014; 349:g5060.
23. Bekaert M, Vansteelandt S, Mertens K. Adjusting for time-varying confounding in the subdistribution analysis of a competing risk. Lifetime Data Anal 2010; 16:45-70.
24. Wolkewitz M, Beyersmann J, Gastmeier P, Schumacher M. Modeling the effect of time-dependent exposure on intensive care unit mortality. Intensive Care Med 2009; 35:826-32.
25. Schumacher M, Wangler M, Wolkewitz M, Beyersmann J. Attributable mortality due to nosocomial infections. A simple and useful application of multistate models. Methods Inf Med 2007; 46:595-600.
26. Beyersmann J, Gastmeier P, Grundmann H, et al. Use of multistate models to assess prolongation of intensive care unit stay due to nosocomial infection. Infect Control Hosp Epidemiol 2006; 27:493-9.
27. Barnett AG, Beyersmann J, Allignol A, Rosenthal VD, Graves N, Wolkewitz M. The time-dependent bias and its effect on extra length of stay due to nosocomial infection. Value Health 2011; 14:381-6.
28. Robins JM, Hernan MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology 2000; 11:550-60.
29. Bekaert M, Timsit JF, Vansteelandt S, et al; Outcomerea Study Group. Attributable mortality of ventilator-associated pneumonia: a reappraisal using causal analysis. Am J Respir Crit Care Med 2011; 184:1133-9.
30. Ong DSY, Bonten MJM, Safdari K, et al. Epidemiology, management and risk-adjusted mortality of ICU-acquired enterococcal bacteremia. Clin Infect Dis 2015; 61:1413-20.
31. Papazian L, Hraiech S, Lehingue S, et al. Cytomegalovirus reactivation in ICU patients. Intensive Care Med 2016; 42:28-37.
32. Nichols WG, Corey L, Gooley T, Davis C, Boeckh M. High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infection. J Infect Dis 2002; 185:273-82.
33. Schafer P, Tenschert W, Schroter M, Gutensohn K, Laufs R. False-positive results of plasma PCR for cytomegalovirus DNA due to delayed sample preparation. J Clin Microbiol 2000; 38:3249-53.
34. Ressing ME, Horst D, Griffin BD, et al. Epstein-Barr virus evasion of CD8(+) and CD4(+) T cell immunity via concerted actions of multiple gene products. Semin Cancer Biol 2008; 18:397-408.